Chemokine genetic polymorphism in human health and disease.
Chemokine receptor-ligand interaction regulates transmigration of lymphocytes and monocytes from circulation to the inflammatory sites. CC chemokine receptors, chemokine receptor 2(CCR2) and 5 (CCR5) are important in recruitment of immune cells as well as non-immune cells under pathological condition. CCR2, CCR5 and their ligands (CCL2 and CCL5) are major contributor to the autoimmune and inflammatory diseases and cancer. Currently studies are being done to explore genetic variations in chemokine genes and their involvement in diseases that could make clear disease severity and deaths. Conflicting results of studies in different populations and diseases promoted to investigate chemokines genetic polymorphisms in miscellaneous diseases. This study is aimed to evaluate the influence of chemokines genetic polymorphisms in pathogenesis and outcome of prevalent non infectious diseases. Present study demonstrates the likely role played by genetic variations in drug response and evolution. Moreover this study highlights chemokine as therapeutic target and diagnostic biomarker in pathological condition.
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow 226025, India. Electronic address: tabish.iet@gmail.com.
Tabish
T
Qidwai
D001327:Autoimmune Diseases / Q000276:immunology*; D002465:Cell Movement / Q000235:genetics / Q000276:immunology; D018925:Chemokines / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D007109:Immunity / Q000235:genetics; D007239:Infections / Q000276:immunology*; D007249:Inflammation / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology*; D009000:Monocytes / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology*; D011110:Polymorphism, Genetic
D018925:Chemokines
Biomarker; Chemokines; Diseases; Drug response; Evolution; Genetic variations; Therapeutic target